XML 70 R45.htm IDEA: XBRL DOCUMENT v2.4.1.9
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2014
Stock based compensation  
Stock-based compensation
Year Ended December 31,2014 2013 2012
(Dollars in thousands)        
Stock option awards $ 15,802 $ 12,973 $ 20,884
Restricted stock unit awards   17,968   15,535   19,025
Deferred compensation bonus and matching stock unit awards   690   550   749
Awards under Non-Employee Director compensation plan   1,333   1,280   1,213
Total stock-based compensation, before income taxes   35,793   30,338   41,871
Income tax benefit   (13,519)   (11,459)   (15,848)
Total stock-based compensation expense, net of income taxes $ 22,274 $ 18,879 $ 26,023
Stock-based compensation, allocation by financial statement line item
December 31,  2014  2013  2012
(Dollars in thousands)        
Selling, general and administrative expense$ 32,505 $ 27,130 $ 38,563
Cost of services and products  3,288   3,208   3,308
Total stock-based compensation$ 35,793 $ 30,338 $ 41,871
Stock-based compensation, fair value assumptions
TDS estimated the fair value of stock options granted in 2014, 2013 and 2012 using the Black Scholes valuation model and the assumptions shown in the table below:
         
 2014 2013 2012
Expected life 5.8 Years  5.7 Years  5.5 Years 
Expected annual volatility rate 39.6% 41.0% 41.1%
Dividend yield 2.0% 2.3% 2.4%
Risk-free interest rate 1.8% 1.0% 0.9%
Estimated annual forfeiture rate 2.9% 2.9% 2.9%

U.S. Cellular estimated the fair value of stock options granted during 2014, 2013, and 2012 using the Black-Scholes valuation model and the assumptions shown in the table below.
       
  2014 2013 2012
Expected life 4.5 years 4.6-9.0 years 4.5 years
Expected annual volatility rate 28.0%-28.1% 29.2%-39.6% 40.7%-42.6%
Dividend yield 0% 0% 0%
Risk-free interest rate 1.4%-1.5% 0.7%-2.4% 0.5%-0.9
Estimated annual forfeiture rate 9.4% 0.0%-8.1% 0.0%-9.1%
Summary of stock options
             Weighted
             Average
    Weighted Weighted    Remaining
    Average Average Aggregate Contractual
  Number of Exercise Grant Date Intrinsic Life
Common Share Options Options Prices Fair Value Value (in years)
Outstanding at December 31, 2011  7,216,000 $ 33.89        
(4,865,000 exercisable)     36.67        
Granted  1,702,000  20.79 $6.28     
Exercised  (1,000)  20.65    $4,000  
Forfeited  (106,000)  23.81        
Expired  (298,000)  30.12        
Outstanding at December 31, 2012  8,513,000 $ 31.53        
(5,782,000 exercisable)     35.12        
Granted  1,259,000  22.60 $7.01     
Exercised  (683,000)  25.33    $2,450,000  
Forfeited  (81,000)  23.75        
Expired  (228,000)  34.10        
Outstanding at December 31, 2013  8,780,000 $30.74        
(6,160,000 exercisable)    34.13        
Granted  930,000  26.83 $8.66     
Exercised  (40,000)  21.28    $174,000  
Forfeited  (73,000)  23.05        
Expired  (457,000)  34.55        
Outstanding at December 31, 2014  9,140,000 $30.25    $9,651,000 5.6
(6,487,000 exercisable)   $32.93    $4,143,000 4.5

             Weighted
             Average
    Weighted Weighted    Remaining
    Average Average Aggregate Contractual
  Number of Exercise Grant Date Intrinsic Life
Common Share Options Options Price Fair Value Value (in years)
              
Outstanding at December 31, 2011  2,834,000 $ 43.07        
(1,533,000 exercisable)     46.23        
Granted   677,000   34.91 $ 12.61     
Exercised   (47,000)   29.82    $ 205,000  
Forfeited   (117,000)   38.45        
Expired   (133,000)   46.17        
Outstanding at December 31, 2012  3,214,000 $ 41.58        
(1,928,000 exercisable)     43.99        
Granted   1,213,000   32.45 $ 11.53     
Exercised   (892,000)   34.78    $ 6,787,000  
Forfeited   (574,000)   34.17        
Expired   (247,000)   48.35        
Outstanding at December 31, 2013  2,714,000 $ 42.22        
(1,359,000 exercisable)     46.91        
Granted   1,116,000   41.21 $ 10.68     
Exercised   (233,000)   32.80    $ 1,966,000  
Forfeited   (144,000)   35.09        
Expired   (65,000)   45.68        
Outstanding at December 31, 2014  3,388,000 $ 41.51    $ 7,495,000  6.70
(1,586,000 exercisable)   $ 45.28    $ 2,984,000  4.40
Summary of nonvested restricted stock units
A summary of TDS nonvested restricted stock units and changes during the year ended December 31, 2014 is presented in the table below:
      
Common Restricted Stock Units Number Weighted Average Grant Date Fair Value
Nonvested at December 31, 2013  663,000 $ 20.43
Granted  355,000 $ 25.26
Vested  (300,000) $ 19.68
Forfeited  (26,000) $ 21.31
Nonvested at December 31, 2014  692,000 $ 23.20

A summary of U.S. Cellular nonvested restricted stock units at December 31, 2014 and changes during the year then ended is presented in the table below:
      
Common Restricted Stock Units Number Weighted Average Grant Date Fair Value
Nonvested at December 31, 2013  1,170,000 $ 36.46
Granted  370,000   41.24
Vested  (274,000)   41.92
Forfeited  (124,000)   34.38
Nonvested at December 31, 2014  1,142,000 $ 35.60